As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

Bayesian methods have emerged as a pivotal framework in the design and analysis of clinical trials, offering a systematic approach for updating evidence as new data become available. By utilising ...

The post How To Speed Up the Search for Cures Through a Change in Probability Theory appeared first on Reason.com.

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Bayesian methods in Structural Equation Modeling (SEM) represent a paradigm shift in statistical analysis, integrating prior beliefs with empirical data to derive robust parameter estimates. This ...

Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity Carcinoma We propose a novel ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...